ESABESAB Corporation
The Read
7% on macro or generic catalysts, with a notable 11.
The schedule
- Thu15Oct
Trade policy evaluation under President Trump modeling a move from $85.00 to $90.50 or $78.00.
- Wed4Nov
Q3 2026 Earnings Release assessing backlog and pricing power from $78.00 to $84.00 or $72.50.
- Tue9Feb
Q4 2026 Earnings and FY2027 Guidance forecasting a test of $84.00 resolving to $90.00 or $77.00.
- Wed5May
Q1 2027 Earnings Release evaluating comparables from $77.00, targeting $83.50 with a $70.00 floor.
- Thu5Aug
Past
- Tue4Aug
Actual outcome: Mixed · $91.86 at outcome
ESAB reported Q2 earnings of $1.33 per share, missing consensus estimates of $1.37 and falling below the prior year's $1.36. Despite management highlighting record core sales and adjusted EBITDA, the bottom-line miss weighed heavily on investor sentiment, driving the stock steadily downward to break the $85.00 bear floor.
Q2 2026 Earnings Release focusing on margin recovery from the $92.78 spot, with downside risk to $85.00 or an upside surprise to $98.08.
- Thu25Jun
Actual outcome: Bear · $98.63 at outcome
ESAB shares broke below the $100 bear floor by the outcome date, as the anticipated federal infrastructure project allocations failed to provide a positive catalyst. Additionally, earlier warnings regarding a negative trend in earnings estimate revisions weighed on investor sentiment, ultimately driving the stock down to $98.63 and continuing its slide into early July.
Initial round of specific project allocations under the current Trump administration's infrastructure initiatives, evaluating direct order volume flow to ESAB's metal fabrication division.
- Sat2May
Actual outcome: Mixed · $101.53 at outcome
Although ESAB shares initially rose 3.7% heading into the outcome date, the stock ultimately fell below the bear floor following its May 7 earnings release. The company slightly missed Q1 EPS estimates ($1.31 versus $1.32 expected) and cited higher costs tied to the conflict in Iran, which overshadowed record first-quarter sales and reaffirmed full-year guidance to drive the subsequent sell-off.
Although ESAB shares initially rose 3.7% heading into the outcome date, the stock ultimately fell below the bear floor following its May 7 earnings release. The company slightly missed Q1 EPS estimates ($1.31 versus $1.32 expected) and cited higher costs tied to the conflict in Iran, which overshadowed record first-quarter sales and reaffirmed full-year guidance to drive the subsequent sell-off.
- Mon30Mar
Actual outcome: Bull · $101.65 at outcome
ESAB shares rallied 11.3% between the event and outcome dates, driven by market speculation highlighting the company as a prime leveraged buyout (LBO) target. The stock's upward momentum was further sustained as investors positively digested the announcement of a CFO transition, pushing the price toward the bull target.
ESAB shares rallied 11.3% between the event and outcome dates, driven by market speculation highlighting the company as a prime leveraged buyout (LBO) target. The stock's upward momentum was further sustained as investors positively digested the announcement of a CFO transition, pushing the price toward the bull target.
- Thu19Feb
Actual outcome: Bear · $125.31 at outcome
ESAB delivered a marginal EPS beat of $1.35 against a $1.34 estimate, but the results failed to satisfy a market that had priced the stock for perfection at a 32.02 P/E. The subsequent collapse to $97.93 by the run date indicates that the 2026 guidance failed to justify the company's significant valuation premium, allowing the high-multiple risk to materialize.
ESAB delivered a marginal EPS beat of $1.35 against a $1.34 estimate, but the results failed to satisfy a market that had priced the stock for perfection at a 32.02 P/E. The subsequent collapse to $97.93 by the run date indicates that the 2026 guidance failed to justify the company's significant valuation premium, allowing the high-multiple risk to materialize.
